Avanos Medical (AVNS) Projected to Post Earnings on Wednesday

Avanos Medical (NYSE:AVNS) will likely be issuing its quarterly earnings data before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $177.23 million for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Avanos Medical Stock Up 1.3 %

AVNS opened at $15.65 on Tuesday. The firm has a market capitalization of $719.37 million, a P/E ratio of 46.04 and a beta of 0.98. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. The company’s 50-day moving average is $16.18 and its 200 day moving average is $19.78. Avanos Medical has a fifty-two week low of $14.98 and a fifty-two week high of $25.36.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.